SLU-PP-332 (1mg) × 60 Tablets

This single-compound research tablet contains SLU-PP-332, a selective AMPK pathway modulator investigated for its role in enhancing energy metabolism and endurance capacity. Developed for researchers studying metabolic activation, mitochondrial performance, and cellular energy regulation, this formulation provides a precise and stable platform for preclinical metabolic and performance research.

Composition (Per Tablet):
SLU-PP-332 – 1mg
60 tablets per bottle

Key Characteristics:

• SLU-PP-332: Investigated as an AMPK pathway activator linked to energy balance, endurance, and metabolic enhancement

• Studied for its effects on mitochondrial biogenesis and fatty acid oxidation

• Oral tablet formulation designed for compound stability and uniform delivery

• Consistent dosage ideal for reproducible research outcomes

Intended Use:
This product is intended for laboratory research use only. It is not for human consumption, therapeutic use, or diagnostic purposes. Any application outside of approved research protocols is strictly prohibited.